It appears that the use of bioresorbable vascular scaffolds (BVS) in patients undergoing percutaneous coronary intervention is linked to higher thrombotic risk and reduced efficacy over time compared with metallic everolimus-eluting stents (EES), a recent study suggests.
The risk of cardiovascular morbidity is reduced in elderly patients who highly adhere to antihypertensive drug therapy, reports a new study. Furthermore, adherence to antihypertensives also lowers the risk of heart failure and stroke, but not myocardial infarction (MI), and extending to all-cause death.
Occasional and weekly chest pain and shortness of breath during activity in patients with cardiovascular disease (CVD) appear to be associated with several modifiable patient characteristics such as weight, psychological health and number of other painful body sites, a study has shown.
Insulin degludec had comparable cardiovascular safety and reduced the risk of severe hypoglycaemia compared with insulin glargine U100 in patients with type 2 diabetes and high cardiovascular risk, according to results of the DEVOTE* study.
Older people who use statins or fibrates to improve lipid profile are less likely to develop stroke, according to a French cohort study. However, both lipid-lowering agents do not exert any protective effect on coronary heart disease (CHD).